Vaccination News Home Page

http://bmj.com/cgi/content/full/325/7354/8

BMJ
 

Home Help Search/Archive Feedback Table of Contents

Abridged text of this article
PDF [abridged] of this article
Email this article to a friend
Respond to this article
Download to Citation Manager
Search Medline for articles by:
Gottlieb, S.
Alert me when:
New articles cite this article
 
Collections under which this article appears:
Family Planning
Cancer: breast

BMJ 2002;325:8 ( 6 July )
 

News roundup

 

New study adds to evidence that taking oral contraception does not increase risk of breast cancer

Scott Gottlieb New York

 

 

A new study shows that older women who have used oral contraceptives are no more likely to develop breast cancer than those who have not, bolstering a growing body of evidence that no link exists.

But researchers cautioned that the new findings were limited to the age group studied and that more research was warranted for younger women.

The study looked at nearly 9300 women aged 35 to 64. About half of the women had developed breast cancer in the middle to late 1990s. The rest were healthy controls.

Interviews with the women showed that similar proportions of these two groups had used contraceptives (79% of the group without cancer, 77% of the group with cancer). The relative risk was 1.0 (95% confidence interval 0.8 to 1.3) for women who were currently using oral contraceptives and 0.9 (0.8 to 1.0) for those who had previously used them.

The risk did not increase with longer periods of use or with higher doses of oestrogen, and the results were similar among white and black women, among women with a family history of breast cancer, and among those who had begun using oral contraception at a young age (New England Journal and Medicine 2002;346:2025-32).

The exception to these findings was among women aged 45 to 64 who were taking the pill to alleviate symptoms of menopause or to reduce their risk of ovarian and endometrial cancer and benign breast disease. The team found a slightly increased risk of breast cancer among these women, but the number of women studied in this group was too small to be significant.

The study focused on older women because of the higher incidence of breast cancer in that age group. The findings essentially matched the results of a major study in 1986 that also showed no association between oral contraceptives and breast cancer.

"We conducted the study to resolve the longstanding concern," said Dr Robert Spirtas, chief of the National Institute of Child Health and Human Development’s Contraception and Reproductive Health branch and one of the authors of the study. "Our study provides yet more scientific proof that there isn’t an association."

In an accompanying editorial, Dr Kathy Helzlsouer and Dr Nancy Davidson of Johns Hopkins University write that "for most women, the benefits of avoiding pregnancy, with its attendant health risks, clearly outweigh these side effects."

But they noted that oral contraceptives could also have other adverse effects, including pulmonary embolism, strokes, liver cancer, and, among smokers who are over age 35, heart problems. Women who have a positive test result for the human papillomavirus are also at increased risk of cervical cancer.
 
 

Abridged text of this article
PDF [abridged] of this article
Email this article to a friend
Respond to this article
Download to Citation Manager
Search Medline for articles by:
Gottlieb, S.
Alert me when:
New articles cite this article
 
Collections under which this article appears:
Family Planning
Cancer: breast


 

 


Home Help Search/Archive Feedback Table of Contents

BMJ Tobacco Control
 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.